Isogenic Human iPSC Parkinson’s Model Shows Nitrosative Stress-Induced Dysfunction in MEF2-PGC1α Transcription
Author(s) -
Scott D. Ryan,
Nima Dolatabadi,
Shing Fai Chan,
Xiaofei Zhang,
Mohd Waseem Akhtar,
James Parker,
Frank Soldner,
Carmen R. Sunico,
Saumya Nagar,
Maria Talantova,
Brian Lee,
Kevin Lopez,
Anthony Nutter,
Bing Shan,
Elena Molokanova,
Yaoyang Zhang,
Xuemei Han,
Tomohiro Nakamura,
Eliezer Masliah,
John R. Yates,
Nobuki Nakanishi,
Alexander Y. Andreyev,
Shuichi Okamoto,
Rudolf Jaenisch,
Rajesh Ambasudhan,
Stuart A. Lipton
Publication year - 2013
Publication title -
cell
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 26.304
H-Index - 776
eISSN - 1097-4172
pISSN - 0092-8674
DOI - 10.1016/j.cell.2013.11.009
Subject(s) - biology , pars compacta , mef2c , rotenone , substantia nigra , mef2 , oxidative stress , microbiology and biotechnology , transcription factor , mitochondrion , induced pluripotent stem cell , parkinson's disease , dopaminergic , genetics , enhancer , biochemistry , dopamine , gene , neuroscience , medicine , disease , embryonic stem cell
Parkinson's disease (PD) is characterized by loss of A9 dopaminergic (DA) neurons in the substantia nigra pars compacta (SNpc). An association has been reported between PD and exposure to mitochondrial toxins, including environmental pesticides paraquat, maneb, and rotenone. Here, using a robust, patient-derived stem cell model of PD allowing comparison of A53T α-synuclein (α-syn) mutant cells and isogenic mutation-corrected controls, we identify mitochondrial toxin-induced perturbations in A53T α-syn A9 DA neurons (hNs). We report a pathway whereby basal and toxin-induced nitrosative/oxidative stress results in S-nitrosylation of transcription factor MEF2C in A53T hNs compared to corrected controls. This redox reaction inhibits the MEF2C-PGC1α transcriptional network, contributing to mitochondrial dysfunction and apoptotic cell death. Our data provide mechanistic insight into gene-environmental interaction (GxE) in the pathogenesis of PD. Furthermore, using small-molecule high-throughput screening, we identify the MEF2C-PGC1α pathway as a therapeutic target to combat PD.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom